PreDiCT-TB coordinators to attend close out meeting with IMI in Brussels

April 25, 2018
No Comments

On 25th April 2018: Gerry Davies and Justin Green will be supported by PreDiCT-TB project manager Philip Whitehead as they head to Brussels this Thursday to present a wide-ranging summary of the 5-year PreDiCT-TB IMI project.

“This has been an amazing, & we believe unique, collaboration between industry, SMEs and academics in the field of TB drug Discovery and Development that all of us have really enjoyed participating in. More importantly we feel we have challenged the bottlenecks that continue to hamper our ability to create and register new medicines for TB patients, bringing new tools & understanding for scientists to use.” (Gerry Davies)

Consortium Partners

PreDiCT-TB brings together twenty-one leading European research partners in tuberculosis from both Industry and Academia

View More

The research leading to these results has received support from the Innovative Medicines Initiative Joint Undertaking under grant agreement n° 115337, resources of which are composed of financial contribution from the European Union's Seventh Framework Programme (FP7/2007-2013) and EFPIA companies’ in kind contribution.

The communication contained within this site reflects the author’s view and neither IMI nor the European Union and EFPIA are liable for any use that may be made of the information contained therein.